|
|
||||||||
Clinical Chemistry, Vol 32, 358-360, Copyright © 1986 by American Association for Clinical Chemistry
RR Little, JD England, HM Wiedmeyer, EM McKenzie, R Mitra, PM Erhart, JB Durham and DE Goldstein
As the clinical utility of glycated hemoglobin (gHb) measurement increases, so does the need for standardization of values between different methods and different laboratories. Using three different methods, we examined the feasibility of interlaboratory standardization of gHb measurement. A liquid-chromatographic (HPLC) system from our research laboratory was designated the reference method. For gHb standards we used erythrocyte hemolysates prepared from blood samples from nondiabetic and diabetic subjects. Values assigned to each standard were based on the mean of multiple gHb determinations by the HPLC method. A clinical laboratory routinely prepared hemolysates and assayed gHb by commercially available ion-exchange ("mini column") and affinity chromatographic methods. For each assay a standard curve was constructed and gHb values were derived from these curves. Samples analyzed in the clinical laboratory were also analyzed in the research laboratory and the curve-derived values were compared with the HPLC- measured values, to determine the accuracy of our interlaboratory standardization procedure. Correlations were excellent (r = 0.99). The lack of significant differences between calculated and HPLC-measured values indicates that interlaboratory standardization is feasible.
The following articles in journals at HighWire Press have cited this article:
![]() |
J. Xu, S. Eilat-Adar, C. M Loria, B. V Howard, R. R Fabsitz, M. Begum, E. M Zephier, and E. T Lee Macronutrient intake and glycemic control in a population-based sample of American Indians with diabetes: the Strong Heart Study Am. J. Clinical Nutrition, August 1, 2007; 86(2): 480 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Burnett, J. M. Devaney, R. J. Adenika, R. Lindsay, and B. V. Howard Cross-Sectional Associations of Resistin, Coronary Heart Disease, and Insulin Resistance J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 64 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Goldstein, R. R. Little, R. A. Lorenz, J. I. Malone, D. Nathan, C. M. Peterson, and D. B. Sacks Tests of Glycemia in Diabetes Diabetes Care, July 1, 2004; 27(7): 1761 - 1773. [Full Text] [PDF] |
||||
![]() |
H. E. Resnick, R. S. Lindsay, M. M. McDermott, R. B. Devereux, K. L. Jones, R. R. Fabsitz, and B. V. Howard Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality: The Strong Heart Study Circulation, February 17, 2004; 109(6): 733 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Lu, H. E. Resnick, K. A. Jablonski, K. L. Jones, A. K. Jain, Wm. J. Howard, D. C. Robbins, and B. V. Howard Non-HDL Cholesterol as a Predictor of Cardiovascular Disease in Type 2 Diabetes: The Strong Heart Study Diabetes Care, January 1, 2003; 26(1): 16 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, E. T. Lee, R. Fabsitz, T. K. Welty, and B. V. Howard Using HbA1c to Improve Efficacy of the American Diabetes Association Fasting Plasma Glucose Criterion in Screening for New Type 2 Diabetes in American Indians: The Strong Heart Study Diabetes Care, August 1, 2002; 25(8): 1365 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Little, C. L. Rohlfing, H.-M. Wiedmeyer, G. L. Myers, D. B. Sacks, and D. E. Goldstein The National Glycohemoglobin Standardization Program: A Five-Year Progress Report Clin. Chem., November 1, 2001; 47(11): 1985 - 1992. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. V. Howard, D. C. Robbins, M. L. Sievers, E. T. Lee, D. Rhoades, R. B. Devereux, L. D. Cowan, R. S. Gray, T. K. Welty, O. T. Go, et al. LDL Cholesterol as a Strong Predictor of Coronary Heart Disease in Diabetic Individuals With Insulin Resistance and Low LDL : The Strong Heart Study Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 830 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Frantzen, K. Grimsrud, D.-E. Heggli, A. L. Faaren, T. Lovli, and E. Sundrehagen Glycohemoglobin filter assay for doctors' offices based on boronic acid affinity principle Clin. Chem., December 1, 1997; 43(12): 2390 - 2396. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Gray, D. C. Robbins, W. Wang, J. L. Yeh, R. R. Fabsitz, L. D. Cowan, T. K. Welty, E. T. Lee, R. M. Krauss, and B. V. Howard Relation of LDL Size to the Insulin Resistance Syndrome and Coronary Heart Disease in American Indians : The Strong Heart Study Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2713 - 2720. [Abstract] [Full Text] |
||||
![]() |
G. Halwachs-Baumann, S. Katzensteiner, W. Schnedl, P. Purstner, T. Pieber, and M. Wilders-Truschnig Comparative evaluation of three assay systems for automated determination of hemoglobin A1c Clin. Chem., March 1, 1997; 43(3): 511 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kataoka, D. C. Robbins, L. D. Cowan, O. Go, J. L. Yeh, R. B. Devereux, R. R. Fabsitz, E. T. Lee, T. K. Welty, and B. V. Howard Apolipoprotein E Polymorphism in American Indians and Its Relation to Plasma Lipoproteins and Diabetes: The Strong Heart Study Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 918 - 925. [Abstract] [Full Text] |
||||
![]() |
B. V. Howard, E. T. Lee, J. L. Yeh, O. Go, R. R. Fabsitz, R. B. Devereux, and T. K. Welty Hypertension in Adult American Indians: The Strong Heart Study Hypertension, August 1, 1996; 28(2): 256 - 264. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |